Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oligonucleotide Conjugates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108738321B details novel GalNAc phosphoramidites for oligonucleotide conjugates, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN116444589B reveals high-yield liquid phase synthesis for GalNAc conjugates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates significantly.
Patent CN117384226B details a high-purity GalNAc synthesis route offering significant cost reduction and supply chain reliability for oligonucleotide drug manufacturing.